Profound Stock Based Compensation from 2010 to 2026
| PROF Stock | USD 6.56 0.26 3.81% |
Stock Based Compensation | First Reported 2014-03-31 | Previous Quarter 1.5 M | Current Value 1.7 M | Quarterly Volatility 572.1 K |
Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 737.9 K or Selling General Administrative of 27.9 M, as well as many indicators such as Price To Sales Ratio of 29.06, Dividend Yield of 0.0 or PTB Ratio of 3.89. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
Profound | Stock Based Compensation | Build AI portfolio with Profound Stock |
The Stock Based Compensation trend for Profound Medical Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Profound Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Profound Medical's Stock Based Compensation Growth Pattern
Below is the plot of the Stock Based Compensation of Profound Medical Corp over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Profound Medical's Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
| Stock Based Compensation | 10 Years Trend |
|
Stock Based Compensation |
| Timeline |
Profound Stock Based Compensation Regression Statistics
| Arithmetic Mean | 1,837,322 | |
| Geometric Mean | 967,307 | |
| Coefficient Of Variation | 104.84 | |
| Mean Deviation | 1,537,217 | |
| Median | 1,064,278 | |
| Standard Deviation | 1,926,162 | |
| Sample Variance | 3.7T | |
| Range | 7M | |
| R-Value | 0.70 | |
| Mean Square Error | 2T | |
| R-Squared | 0.50 | |
| Significance | 0 | |
| Slope | 268,578 | |
| Total Sum of Squares | 59.4T |
Profound Stock Based Compensation History
Other Fundumenentals of Profound Medical Corp
Profound Medical Stock Based Compensation component correlations
Click cells to compare fundamentals
About Profound Medical Financial Statements
Profound Medical stakeholders use historical fundamental indicators, such as Profound Medical's Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Profound Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Profound Medical's assets and liabilities are reflected in the revenues and expenses on Profound Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Profound Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Stock Based Compensation | 3 M | 2.5 M | |
| Stock Based Compensation To Revenue | 0.22 | 0.38 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Profound Medical Correlation against competitors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share (1.32) | Revenue Per Share | Quarterly Revenue Growth 0.868 | Return On Assets | Return On Equity |
Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.